Get email updates from SABCSMeetingNews.org
Subscribe to get regular news updates from SABCS.org and SABCS Meeting News.
DECEMBER 6–10, 2022
Henry B. Gonzalez Convention Center
|
San Antonio, TX
-
Special ‘C. Kent Osborne Symposium’ to focus on HER2, ER crosstalk
In recognition of his pioneering work on the interplay between ER and HER2 signaling, Dr. Osborne will be the special guest at this symposium bearing his name. Speakers will explore what is known about the crosstalk between these signaling pathways, how it takes place, and the latest evidence on the most effective therapies for patients who are ER+ and HER2+.
-
Clinical Controversies: Experts debate topics in breast cancer treatment, research
In the first of two new ‘Controversies’ sessions at SABCS 2022, Lisa Carey, MD, ScM, FASCO, will lead discussions by experts on three important topics in breast cancer clinical care.
-
Clinical Research Workshop will focus on drug development, adherence in clinical trials
Aditya Bardia, MD, MPH, will moderate this year’s Clinical Research Workshop. Among the presentations, Dawn L. Hershman, MD, MS, will discuss drug adherence in clinical trials.
-
Early-Bird discount ends soon — book your housing and register today!
SABCS offers attendees the option to participate in person in San Antonio or virtually from anywhere in the world. Special early-bird pricing is available for both in-person and virtual registrations until October 31.
-
Highlights from the Program Committee
SABCS Program Planning Committee members Sibylle Loibl, MD, PhD, and Fabrice André, MD, PhD, talk about what they are most looking forward to at SABCS 2022.
-
In person or virtual — network and connect at #SABCS22
In addition to a cutting-edge scientific program, SABCS 2022 will offer attendees a variety of opportunities to engage, interact, and network with speakers, exhibitors, and one another.
-
SABCS 2022: Spotlight on Clinical Science
From the latest clinical trial results to the newest therapies finding their way to the clinic, the SABCS 2022 scientific program showcases the most important and most impactful clinical advances in breast cancer treatment.
-
Highlights from the Program Committee — The Patient Perspective
Patient advocate and SABCS Program Planning Committee member Thelma Brown, BSc, talks about what she’s looking forward to at SABCS 2022 and why you will not want to miss this year’s meeting.
-
Final call for late-breaking abstract submissions
Regular abstract submission has closed, but there is still time to submit late-breaking abstracts for consideration. The deadline to submit a late-breaking abstract is September 30.
-
Why attend #SABCS22? — Highlights from the Program Committee
SABCS Program Committee members Andrea V. Barrio, MD, FACS, and Kalliopi P. Siziopikou, MD, PhD, talk about the value of SABCS and why you will not want to miss this year’s meeting.